Management of hfe hemochromatosis;Prise en charge de l'hémochromatose liée au gène HFE

Presse Medicale

Volumn 36, Issue 9 II, 2007, Pages 1295-1300

  Brissot, Pierre ^a   De Bels, Frédéric ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Ancien Délégué Général de la Fédération de l'Hospitalisation Privée   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN; FERRITIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

GENE EXPRESSION; GENE MUTATION; GENETIC COUNSELING; HEMOCHROMATOSIS; HUMAN; PHENOTYPE; PHLEBOTOMY; SHORT SURVEY; TREATMENT CONTRAINDICATION; BLOOD; FEMALE; GENETICS; HOSPITALIZATION; MALE; METABOLISM; METHODOLOGY; POINT MUTATION; REVIEW;

FEMALE; FERRITINS; GENE EXPRESSION; GENETIC COUNSELING; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; PHENOTYPE; PHLEBOTOMY; POINT MUTATION; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 34548304984     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2006.12.035     Document Type: Short Survey

References (4)

1. Brissot P., Troadec M.B., and Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr Hematol Rep 3 (2004) 107-115
2. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 350 (2004) 2383-2397
3. HAS. Recommandations pour la prise en charge de l'hémochromatose HFE; 2005. www.has-sante.fr.
4. Brissot P., Le Lan C., Troadec M.B., Lorho R., Ropert M., Lescoat G., et al. HFE hemochromatosis: pathogenic and diagnostic approach. Transfus Clin Biol 12 (2005) 77-82